We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Sets Priority Review Voucher Redemption Fee at $5.3 Million for Fiscal 2012
FDA Sets Priority Review Voucher Redemption Fee at $5.3 Million for Fiscal 2012
September 1, 2011
Drugmakers redeeming an FDA tropical disease priority review voucher in fiscal 2012 would pay about $5.3 million in addition to the standard user fee, the agency says.